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Abstract
Background: Recently, cytology has been applied to the diagnosis of oral lesions. We aimed to explore the
diagnostic accuracy of oral cytology based on the histological diagnosis.
Methods: Histological diagnoses of 327 cases were classified as Negative, Borderline lesion –, Borderline lesion +,
oral intraepithelial neoplasia/carcinoma in situ (OIN/CIS), or Positive. Cytological diagnoses were classified as NILM
(negative for intraepithelial lesion or malignancy), LSIL (low-grade squamous intraepithelial lesion), HSIL (high-grade
squamous intraepithelial lesion), or SCC (squamous cell carcinoma). The cytology slides were evaluated by 10 raters
and the results were compared with the histology results.
Results: In 142 cases that were histologically negative, the number of NILM, LSIL, HSIL, and SCC and other
malignancy was 77 (54.2%), 47 (34.3%), 8 (5.6%), and 10 (7.0%), respectively. Among 32 cases of Borderline lesion –,
the number of NILM, LSIL, HSIL, and SCC and other malignancy was 11 (34.3%), 11 (34.3%), 9 (28.1%), and 1 (3.1%),
respectively. Also, in 4 cases of Borderline lesion +, the number of NILM, LSIL, HSIL, and SCC and other malignancy
was 2 (50.0%), 0 (0.0%), 0 (0.0%), 2 (50.0%), respectively. Among 12 cases of OIN/CIS, the number of NILM, LSIL, HSIL,
and SCC and other malignancy was 1 (8.3%), 2 (16.7%), 4 (33.3%), and 5 cases (41.7%), respectively. Among 137
cases with a histological diagnosis of Positive, the number of NILM, LSIL, HSIL, and SCC and other malignancy
was 7 (5.1%), 22 (16.1%), 19 (13.9%), and 89 (65.0%), respectively. Sensitivity, specificity, and positive predictive and
negative predictive values were 93.5, 50.6, 62.4, and 89.8%, respectively, when the cytological diagnosis of Negative
was assumed to be NILM; they were 77.8, 83.9, 81.0 and 81.1%, respectively, if the cytological diagnosis of Negative
was assumed to be NILM and LSIL. The number of false-positive and false-negative diagnosis affected cases with
LSIL and HSIL may indicate the difficulty in the cytological diagnosis of borderline lesions. While the negative
predictive value was relatively high (89.8%) when cytological Negative was assumed to be NILM only.
Conclusion: Histopathological examination should be recommended in cases with cytological diagnoses of LSIL,
HSIL, and SCC.
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Background
Exfoliative cytology is a reliable tool for assessing malig-
nant change in various organs [1]. Cytology has been also
applied to the diagnosis of oral lesions [2–4]. Accurate
cytological diagnosis of oral lesions, especially in distin-
guishing benign lesions from malignant ones, is essential
for treatment as well as for clinical and epidemiological
research including the study of prognosis [5].
With respect to cytological diagnosis, the classification
of cervicovaginal smears into five classes was initially
proposed by Papanicolaou, who formulated a series of
guidelines for smear interpretation [6]. This system was
generally well received, although the significance of the
classes was often modified to meet the requirements of la-
boratories in consultation with clinicians [7]. In December
1988, a committee of experts who convened under the
auspices of the National Cancer Institute (USA) in
Bethesda, Maryland, proposed a diagnostic system for
the interpretation of cervicovaginal smears. The result-
ing Bethesda System (modified in 2001) was officially
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accepted by the federal authorities in the United States
[8]. Recently, this system has been used in various fields
such as thyroid, renal, and female genital cytology [9].
Fuller et al. pointed out that although oral cytology
seems to have a higher diagnostic value, further study is
needed to assess this [10]. However, the accuracy of oral
cytology is unknown. Similar to other fields, diagnosis in
oral cytology has been based on the Papanicolaou classi-
fication, not by Bethesda System [8, 9]. However, there
had been no established diagnostic guideline in Japan.
The Japanese Society of Clinical Cytology (JSCC) then
organized a working group for oral cytology to confirm
the accuracy of oral cytology according to Bethesda
System [8, 9] in 2013, and established a diagnostic guide-
line committee for oral cytology in 2013.
This study investigated the clinical applicability of oral
cytology following Bethesda System [8, 9] before the pub-
lication of diagnostic guideline by JSCC [11] by exploring
the diagnostic accuracy of oral cytology based on histo-
logical diagnosis as the gold standard.
Methods
Samples
Patients diagnosed with oral disease were examined in
this study. All cytology samples were prepared from
benign or malignant oral lesions for biopsy and/or
surgically resection. The samples were prepared by
smearing collected cells on glass slides, which were
then immersed in 95% ethanol, fixed, and stained with
Papanicolaou staining. The samples derived from the pa-
tient population had results of oral cytology. Data from
five Japanese institutions were included (Department of
Oral and Maxillofacial Surgery, Shimane University
Faculty of Medicine; Department of Oral Pathology,
School/Graduate School of Dentistry Osaka University;
Second Department of Oral and Maxillofacial Surgery,
Osaka Dental University; Department of Health Promo-
tion, Division of Oral Pathology, Kyushu Dental University
and Department of Oral Pathology, Division of Oral
Pathogenesis and Disease Control, Asahi University
School of Dentistry). The samples (including data) were
retrospectively collected in clinical practice between
October 2007 and November 2013, and cytological and
histological tests were performed simultaneously.
This study was planned and performed following
STARD checklist for reporting of studies of diagnostic ac-
curacy (http://www.stard-statement.org) (data not shown).
Procedure of cytological diagnosis
All the raters who passed the board examination for cy-
tology of JSCC reviewed the samples. The slides were
evaluated independently by at least two raters, and a
representative cytology result of each case was deter-
mined by a majority vote.
Cytological diagnoses were performed based on Bethesda
System [8, 9], and were classified into NILM (negative for
intraepithelial lesion or malignancy), LSIL (low-grade squa-
mous intraepithelial lesion), HSIL (high-grade squamous
intraepithelial lesion), SCC (squamous cell carcinoma), and
IFN (indefinite for neoplasia or non-neoplasia) (Table 1).
Procedure of histological diagnosis
A histological diagnosis was provided by oral patholo-
gists at each institution, and then the number of biopsy
samples was determined at the investigator’s discretion.
These histological slides underwent hematoxylin and
eosin staining. Their histological findings were classi-
fied into five categories as follows. Negative was defined
as non-malignant lesions including inflammatory ones;
Borderline lesion – was defined as mild, mild–moderate,
or moderate dysplasia; Borderline lesion + was defined as
severe dysplasia; OIN/CIS was defined as oral intraepithe-
lial neoplasia or carcinoma in situ; and “Positive” was de-
fined as squamous cell carcinoma and other malignancies.
Borderline lesion – and Borderline lesion + were prepared
based on general rules for clinical and pathological studies
on oral cancer [11, 12].
Accordingly, the results of representative cytology were
compared with the histology results.
Statistical analysis
To compare between cytological and histological diagnosis,
the histological diagnoses were classified into Negative
(Negative and Borderline lesion –) and Positive (Borderline
lesion +, OIN/CIS and Positive), and cytological diagnosis
were also classified into Negative (NILM) and Positive
(LSIL, HSIL, SCC, Other malignancy) or Negative (NILM
and LSIL) and Positive (HSIL, SCC, Other malignancy). To
examine the diagnostic performance by comparing their
cytological diagnosis against the histological diagnosis, the
sensitivity, specificity, positive predictive value, and negative
Table 1 Diagnostic guideline for oral cytology, proposed by the
Diagnostic Guideline Committee for Oral Cytology of the
Japanese Society of Clinical Cytology
Abbreviation Corresponding pathological diagnosis
NILM normal, infection, inflammation, lichen planus,
leukoplakia, benign epithelial lesion, etc.
LSIL mild and moderate dysplasia, and SIN1 and
SIN2; mentioned in WHO 2005
HSIL severe dysplasia, carcinoma in situ, and SIN3;
mentioned in WHO 2005
SCC squamous cell carcinoma
Other malig. other malignancy
IFN indefinite for neoplasia or non-neoplasia
Cytological diagnoses were classified as NILM (negative for intraepithelial
lesion or malignancy), LSIL (low-grade squamous intraepithelial lesion), HSIL
(high-grade squamous intraepithelial lesion), or SCC (squamous cell carcinoma)
and IFN (indefinite for neoplasia or non-neoplasia)
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predictive value were calculated, and all statistical analysis
was performed using SAS version 9.3 (Cary, NC).
Results
Samples
A total of 423 samples of oral cytology with accom-
panying histological slides from five institutions were
screened. Among the 423 samples, 96 samples (22.7%)
were excluded from the study because of poor quality
(e.g., scant cellularity or air-drying artifact). The
remaining 327 samples were reviewed. The remaining
327 samples were reviewed by 10 raters. Among these
samples, 93, 47, 82, 80, 18, 1, and 6 samples were
reviewed by 2, 3, 4, 5, 6, 7, 8 raters, respectively
(Table 2).
Histological diagnosis
The histological diagnoses of 327 cases were classified as
Negative, Borderline lesion –, Borderline lesion +, OIN/
CIS, or Positive (Table 3).
Result of cytological diagnosis compared with histological
diagnosis
Table 4 shows the results for cytological diagnoses
compared with histological diagnoses. In 142 cases that
were histologically negative, the number of patients
with NILM, LSIL, HSIL, and SCC and other malig-
nancy was 77 (54.2%), 47 (34.3%), 8 (5.6%), and 10
(7.0%), respectively. Among the 32 cases of Borderline
lesion –, the number of patients with NILM, LSIL, HSIL,
and SCC and other malignancy was 11 (34.3%), 11
(34.3%), 9 (28.1%), and 1 (3.1%), respectively. Also, in the
4 cases of Borderline lesion +, the number of patients with
NILM, LSIL, HSIL, and SCC and other malignancy was 2
(50.0%), 0 (0.0%), 0 (0.0%), 2 (50.0%), respectively. Among
the 12 cases of OIN/CIS, the number of patients with
NILM, LSIL, HSIL, and SCC and other malignancy was 1
(8.3%), 2 (16.7%), 4 (33.3%), and 5 cases (41.7%), respect-
ively. Among 137 cases with a histological diagnosis of
Positive, the number of patients with NILM, LSIL, HSIL,
and SCC and other malignancy was 7 (5.1%), 22 (16.1%),
19 (13.9%), and 89 (65.0%), respectively.
Distribution of histological diagnoses from the viewpoint
of cytological diagnosis
Fig. 1 shows the distribution of histological diagnoses
from the viewpoint of cytological diagnosis. Among
cases with a cytological diagnosis of NILM (98 cases),
78.6, 11.2, 2.0, 1.0, and 7.1% had a histological diagnosis
of Negative, Borderline lesion –, Borderline lesion +,
OIN/CIS, and Positive, respectively. Among cases with a
cytological diagnosis of LSIL (82 cases), 57.3, 13.4, 0.0,
2.4, and 26.8% had a histological diagnosis of Negative,
Borderline lesion –, Borderline lesion +, OIN/CIS, and
Positive, respectively.
On the other hand, among cases with a cytological
diagnosis of HSIL (40 cases) 20.0, 22.5, 0.0, 10.0, and
47.5% had a histological diagnosis of Negative, Borderline
lesion –, Borderline lesion +, OIN/CIS, and Positive, re-
spectively. Among cases with cytological diagnoses of SCC
or Other malignancy (107 cases), 9.3 , 0.9, 1.9, 4.7, and
83.2% had a histological diagnosis of Negative, Borderline
lesion –, Borderline lesion +, OIN/CIS, and Positive,
respectively.
Diagnostic performance of cytological diagnoses
With respect to cytological diagnostic performance, the
sensitivity, specificity, positive predictive value, were 93.5,
Table 2 The numbers of reviewing samples per number of raters













































OIN oral intraepithelial neoplasia, CIS carcinoma in situ
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50.6, 62.4, and 89.8% when cytological Negative was
assumed to be NILM only, respectively (Table 5). Also,
these measures were 77.8, 83.9, 81.0, and 81.1% when
cytological Negative was assumed to be NILM and LSIL
(Table 5).
Discussion
The cytological collection had various methods and in-
struments. In this study, all samples were conventionally
smeared and Papanicolaou stained, although recently
liquid-based cytology has become common in the field
of gynecology [13, 14]. The conventional method is still
common in the field of oral and maxillofacial surgery,
despite the technical error of delay in fixation of the
smear sample leads to an air-drying artifact [4]. Actually,
in this study, 96 slides (22.7%) were deemed inadequate
for review due to scant cellularity or air-drying artifact,
all of which were prepared in one institution. Also, these
inadequate samples were partially due to the fact that
cytology instruments do not obtain a sample from the
lesion [4], because the cytological instruments varied
from cotton swabs to intratooth brush in period of sample
collection. To improve the quality of the cytology slides,
the methods and instruments of cytological collection
should be reconsidered and standardized.
As most of oral neoplasms originated in squamous cell
epithelium, the squamous epithelium should be deeply
reviewed for accurate histological diagnosis of oral
lesions [15]. In the field of oral histopahology, there has
been controversy for classification or severity of oral

















NILM (n = 98) 77 (54.2%) 11 (34.3%) 2 (50.0%) 1 (8.3%) 7 (5.1%)
LSIL (n = 82) 47 (34.3%) 11 (34.3%) 0 (0.0%) 2 (16.7%) 22 (16.1%)
HSIL (n = 40) 8 (5.6%) 9 (28.1%) 0 (0.0%) 4 (33.3%) 19 (13.9%)
SCC (n = 104) 9 (6.3%) 1 (3.1%) 2 (50.0%) 5 (41.7%) 87 (63.5%)
Other malignancy (n = 3) 1 (0.7%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (1.5%)
NILM negative for intraepithelial lesion or malignancy, LSIL low-grade squamous intraepithelial lesion, HSIL high-grade squamous intraepithelial lesion, SCC squamous
cell carcinoma, OIN oral intraepithelial neoplasia, CIS carcinoma in situ
Fig. 1 Distribution of the 327 cases with a histological diagnosis in each cytological diagnostic category. The percentages are shown above
the columns
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epithelial dysplasia (OED) into categories of Borderline
lesions + or – [12]. According to a literature [16], mild
epithelial dysplasia refers to alteration in limited to the
basal and parabasal layers, moderate epithelial dysplasia
refers to alteration in the basal to mid-portion of the
spsinous layer, and severe epithelial dysplasia refers to
alteration that affect more than half of the thickness of
the epithelium.
Because most dyslpastic changes occur in the basal
and parabasal layers [17], to obtain a sample from the
deepest layer of lesion is important to make an accurate
cytological diagnosis of oral lesions derived from squa-
mous cells. Further, because most cases of oral SCC are
the differentiated type and are different from cervical
SCC, most of the superficial cells of these lesions are
not malignant and could be a reason of a false-negative
diagnosis. An another reason for these “misdiagnoses”
can be that the nuclear morphology of oral epithelial
cells is easily affected by malignant transformation as
well as inflammation and oral bacilli, so the shape of
the nuclei would seem to be atypical and dysplastic,
which would make accurate diagnosis in oral cytology
difficult [14].
The uncertain cytological diagnosis of borderline
lesions may affect our results as shown in Figure 1.
However, in previous study [4, 18–20], detail of diagnoses
in borderline lesions was not available. In future, the de-
tailed information for borderline lesions should be investi-
gated regarding the oral cytological diagnoses.
As borderline lesions diagnosed as LSIL and HSIL
are then indicated for surgical resection in our hospital
[5, 21], we strongly recommend that cases with cyto-
logical diagnoses of LSIL, HSIL SCC and Other malig-
nancy should belong to the category of cytological
positive. In our study, the number of false-positive and
false-negative diagnosis affected cases with LSIL and
HSIL may indicate the difficulty in the cytological
diagnosis of borderline lesions (Table 4, Fig. 1). While
the negative predictive value was relatively high (89.8%,
Table 5) when cytological Negative was assumed to be
NILM only.
As with most white oral lesions, the color is derived
from the thickened keratin layer or thickened spinous
layer, which masks the vascularity (redness) of the
underlying connective tissue [16]. Accurate diagnosis of
such white lesions is clinically difficult [16, 17], and a
precise diagnosis of dysplasia in intraepithelial lesions
is difficult even in histopathologic specimens [16].
Recently, Sekine et al [21] reported that nucleus
accumbens-associated protein 1 (NAC1) has the poten-
tial to be used as a biomarker for distinguishing OED
from CIS/OSCC. Standardization of the diagnosis of
borderline lesions such as epithelial dysplasia is needed
from a cytopathological viewpoint. There are very few
studies on the accuracy of oral cytology [22], so it still
remains unknown whether our results are satisfactory.
In this study, the cytology slides were evaluated by 10
raters and the results were compared with the histology
results. Though each rater evaluated certain samples
only one time in this study, one limitation was that the
intra-examiner reliability was not able to be evaluated.
In future, however, we will design and perform the
further study to evaluate intra-examiner reliability on
cytological diagnosis for oral cancer. Furthermore, revi-
sion of diagnostic guideline by JSCC [11] should be
needed, as detailed classification, such as atypical squa-
mous cells of undetermined significance (ASC-US) and
atypical squamous cells cannot exclude HSIL (ASC-H)
in the field of gynecology, should be considered to
achieve more accurate diagnosis for borderline lesions
in oral cytology.
Conclusion
In conclusion, histopathological examination should be
recommended in cases with cytological diagnoses of LSIL,
HSIL, and SCCC.
Abbreviations
ASC-H: Atypical squamous cells cannot exclude hsil; ASC-US: Atypical
squamous cells of undetermined significance; CIN: Cervical intraepithelial
neoplasia; CIS: Carcinoma in situ; HSIL: High-grade squamous intraepithelial
lesion; IFN: Indefinite for neoplasia or non-neoplasia; JSCC: The Japanese
society of clinical cytology; LSIL: Low-grade squamous intraepithelial lesion;
NAC1: Nucleus accumbens-associated protein 1; NILM: Negative for



















Worse than NILM 143 86 93.5 50.6 62.4 89.8
NILM 10 88
Worse than LSIL 119 28 77.8 83.9 81.0 81.1
NILM or LSIL 34 146
NILM negative for intraepithelial lesion or malignancy, LSIL low-grade squamous intraepithelial lesion, HSIL high-grade squamous intraepithelial lesion, SCC squamous
cell carcinoma, OIN oral intraepithelial neoplasia, CIS carcinoma in situ, a: Positive included Positive, OIN/CIS, and Borderline lesion + based on the result of
histopathological diagnosis, and Negative included Negative and Borderline lesion –
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intraepithelial lesion or malignancy; OED: Oral epithelial dysplasia; OIN: Oral
intraepithelial neoplasia; SCC: Squamous cell carcinoma
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